PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Church MK et al. Non-IgE-dependent bacteria-induced histamine release from human lung and tonsillar mast cells. 1987 Clin. Allergy pmid:2441900
Kosaka Y et al. Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung. 1987 Agents Actions pmid:2442981
Pipkorn U et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. 1987 J. Clin. Invest. pmid:2443539
Williams KA et al. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. 1987 Biochem. J. pmid:2444206
Lawrence ID et al. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. 1987 J. Immunol. pmid:2444649
Tachi M et al. Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. 2014 Auton Neurosci pmid:24447364
pmid:24456221
Levi-Schaffer F et al. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. 1987 J. Immunol. pmid:2445814
Kumar S et al. Phaseolin: a 47.5kDa protein of red kidney bean (Phaseolus vulgaris L.) plays a pivotal role in hypersensitivity induction. 2014 Int. Immunopharmacol. pmid:24468678
pmid:24471457
Benyon RC et al. Prostaglandin D2 release from human skin mast cells in response to ionophore A23187. 1987 Br. J. Pharmacol. pmid:2447989
Schulman ES et al. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. 1988 J. Clin. Invest. pmid:2449462
Han XQ et al. Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24496672
Heavey DJ et al. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. 1988 J. Immunol. pmid:2450136
Robinson C et al. The immunoglobulin E- and calcium-dependent release of histamine and eicosanoids from human dispersed mastocytosis spleen cells. 1988 J. Invest. Dermatol. pmid:2450144
Holgate ST et al. The contribution of mast cell mediators to acute allergic reactions in human skin and airways. 1988 Allergy pmid:2451448
Jeong KT et al. Anti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis. 2014 BMC Complement Altern Med pmid:24521096
Nieves A and Garza LA Does prostaglandin D2 hold the cure to male pattern baldness? 2014 Exp. Dermatol. pmid:24521203
Bhargava S Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer. 2014 Med. Hypotheses pmid:24548754
Schulman ES et al. Density heterogeneity of human lung mast cells. 1988 J. Allergy Clin. Immunol. pmid:2455745
pmid:24565634
Yen CC et al. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. 2014 Oncotarget pmid:24566468
Brugha RE et al. Carbon in airway macrophages from children with asthma. 2014 Thorax pmid:24567296
pmid:24568186
pmid:24571868
Chen S et al. 15-Deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells. 2014 Chem. Biol. Interact. pmid:24582817
Ormerod AD et al. Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. 1988 J. Allergy Clin. Immunol. pmid:2459177
Undem BJ et al. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. 1988 J. Pharmacol. Exp. Ther. pmid:2459368
Keery RJ and Lumley P AH6809, a prostaglandin DP-receptor blocking drug on human platelets. 1988 Br. J. Pharmacol. pmid:2460179
Barr RM et al. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. 1988 Br. J. Pharmacol. pmid:2460180
Michel L et al. Prostaglandin D2 generation in mouse bone marrow-derived mast cells exposed to dexamethasone is associated with endogenous peroxidase activity. 1988 Lab. Invest. pmid:2460694
Lebel B et al. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. 1988 J. Allergy Clin. Immunol. pmid:2461405
Bousquet J et al. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. 1988 J. Allergy Clin. Immunol. pmid:2461406
Church MM et al. The mediator and cellular basis of the allergic response. 1988 Allergy pmid:2462372
Takei M et al. Role of cyclic AMP during histamine release. Histamine release is not directly related to increase in cyclic AMP levels in rat mast cells activated by concanavalin A, anti-IgE, antigen, prostaglandin D2 and isoproterenol. 1988 Biol. Chem. Hoppe-Seyler pmid:2463844
pmid:24639050
Jeon KI et al. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation. 2014 Am. J. Pathol. pmid:24650561
Marone G Control mechanisms of mediator release in human basophils and mast cells. 1988 Nov-Dec Immunol. Invest. pmid:2465995
Miadonna A et al. Mediators and allergic inflammation of human airways. 1988 Respiration pmid:2466314
Trist DG et al. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. 1989 Br. J. Pharmacol. pmid:2466517
pmid:24680891
Lebel B et al. Spontaneous and non-specific release of histamine and PGD2 by bronchoalveolar lavage cells from asthmatic and normal subjects: effect of nedocromil sodium. 1988 Clin. Allergy pmid:2468432
Carrier EJ et al. Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA. 2014 Biochemistry pmid:24684440
Triggiani M et al. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468619
Charlesworth EN et al. Cells and secretagogues involved in the human late-phase response. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468620
Church MK et al. Interaction of neuropeptides with human mast cells. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468622
Charlesworth EN et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. 1989 J. Clin. Invest. pmid:2468688
Ohuchi K et al. Stimulation of histamine release and arachidonic acid metabolism in rat peritoneal mast cells by thapsigargin, a non-TPA-type tumor promoter. 1989 Biochim. Biophys. Acta pmid:2469475
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Koyani CN et al. 15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. 2014 Int. J. Cardiol. pmid:24698234
Tippin BL et al. Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR. 2014 Cancer Med pmid:24729479
Tang J et al. Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. 2014 Stem Cells Dev. pmid:24730450
Church MK et al. Mast cells, neuropeptides and inflammation. 1989 Agents Actions pmid:2473641
van Overveld FJ Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. 1989 Agents Actions pmid:2473645
Takeshima Y [Development of novel therapeutic approaches for Duchenne muscular dystrophy]. 2014 No To Hattatsu pmid:24738186
Benyon RC et al. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. 1989 Br. J. Pharmacol. pmid:2474353
Ikai K et al. Inhibitory effect of tranilast on prostaglandin D synthetase. 1989 Biochem. Pharmacol. pmid:2475113
pmid:24755408
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. 1989 Prostaglandins pmid:2475889
Dubertret L et al. Biological and cellular responses to grass pollen in sensitive patients. 1989 Dermatologica pmid:2476344
pmid:24767875
Wachs M et al. Observations on the pathogenesis of nasal priming. 1989 J. Allergy Clin. Immunol. pmid:2477429
Stürzebecher S et al. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets. 1989 Prog. Clin. Biol. Res. pmid:2477855
Cohan VL et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. 1989 Am. Rev. Respir. Dis. pmid:2478059
Reshef A et al. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). 1989 J. Allergy Clin. Immunol. pmid:2478604
Marone G et al. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. 1989 Life Sci. pmid:2480501
Kuroyanagi G et al. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Prostaglandins Leukot. Essent. Fatty Acids pmid:24813642
Mello CF and Oliveira MS Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control. 2014 Exp. Neurol. pmid:24814715
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
pmid:24820432
Levi-Schaffer F and Shalit M Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2482257
Stenson WF The universe of arachidonic acid metabolites in inflammatory bowel disease: can we tell the good from the bad? 2014 Curr. Opin. Gastroenterol. pmid:24837228
Iwanaga K et al. Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice. 2014 Cancer Res. pmid:24879565
Steinke JW et al. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. 2014 J. Immunol. pmid:24890720
Casali CI et al. Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells. 2014 Biochem. Pharmacol. pmid:24915420
Kim HJ et al. ROSics: chemistry and proteomics of cysteine modifications in redox biology. 2015 Mar-Apr Mass Spectrom Rev pmid:24916017
Mantel A et al. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. 2014 Exp. Dermatol. pmid:24917395
Pradhan A and Olsson PE Juvenile ovary to testis transition in zebrafish involves inhibition of ptges. 2014 Biol. Reprod. pmid:24920039
Sturm EM et al. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. 2014 J. Immunol. pmid:24929001
Asbóth G et al. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation. 1989 Biochim. Biophys. Acta pmid:2493805
Cichocka-Jarosz E et al. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children. 2014 Ann Agric Environ Med pmid:24959779
Froissart P et al. Modulation by phorbol 12-myristate 13-acetate of arachidonic acid release from rat basophilic leukemia cells stimulated with A23187. 1989 Biochim. Biophys. Acta pmid:2496761
Shivers KY et al. PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. 2014 Biochim. Biophys. Acta pmid:24970746
pmid:24975423
Yoshimura S et al. Prostaglandin D2 receptor of mastocytoma P-815 cells--possible regulation by phosphorylation and dephosphorylation. 1989 Biochim. Biophys. Acta pmid:2497784
Paakinaho V et al. Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation. 2014 Mol. Cell. Biol. pmid:24980431
pmid:24985010
Song Y et al. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:25001926
Elremaly W et al. Ascorbylperoxide from parenteral nutrition induces an increase of redox potential of glutathione and loss of alveoli in newborn guinea pig lungs. 2014 Redox Biol pmid:25009773
Lapointe DS and Olson MS Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. 1989 J. Biol. Chem. pmid:2501299
pmid:25016088
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Robinson C et al. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. 1989 J. Invest. Dermatol. pmid:2504819
Ikai K et al. Prostaglandin D2, a mediator in both immediate and delayed-type immune reactions in the skin. 1989 Dermatologica pmid:2506083
pmid:25072357
Hatanaka M et al. Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells. 1989 J. Neurochem. pmid:2507741
Wasinger C et al. Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. 2014 Br. J. Pharmacol. pmid:25091578
Wong GW et al. Ancient origin of mast cells. 2014 Biochem. Biophys. Res. Commun. pmid:25094046
Urade Y et al. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. 1989 J. Immunol. pmid:2509561
Ito S et al. Prostaglandin D2: a biochemical perspective. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2510183